RAD December 2021 Conference Abstracts and Posters
All accepted abstracts will be published in the British Journal of Dermatology.620 - IL-13 and IL-4 Promote Proliferation and mRNA Expression of MUC2 and MUC5AC in Primary Human Conjunctival Goblet Cells
Maxim A.X. Tollenaere, Pernille Rævdal, Steffen Nagstrup, Anne Heegaard, Mads Roepke, Shannon Schneider, Hanne Norsgaard, Jacob P. Thyssen, Miriam Kolko
623 - Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
Emma Guttman-Yassky, Ana Pavel,1Kenji Kabashima, Delphine Staumont-Salle, Kilian Eyerich, Walter Nahm, Sylvia Pauser, Joel Correa Da Rosa, Mads Roepke, Petra Amoudruz, Shannon Schneider, Andrew Blauvelt, Kristian Reich
626 - CONTENT VALIDITY AND ASSESSMENT OF THE PSYCHOMETRIC PROPERTIES AND SCORE INTERPRETATION OF A SLEEP-LOSS SCALE SCORE IN ATOPIC DERMATITIS
Gil Yosipovitch, Alissa Rams, Jessica Baldasaro, Laurine Bunod, Laure Delbecque, Sara Strzok, Juliette Meunier, Hany Elmaraghy, Luna Sun, Evangeline Pierce
627 - Examining the association of sleep disturbances with older adult age in atopic dermatitis patients
Jaya Manjunath, BS and Jonathan I. Silverberg, MD, PhD, MPH
632 - Epidemiology and burden of atopic dermatitis involving the head, neck, face, and hand: a cross sectional study from the TARGET-DERM AD cohort
Jonathan I Silverberg, Brenda Simpson, Katrina Abuabara, Emma Guttman-Yassky, Brian Calimlim, Colleen Wegzyn, Whitney Krueger, Amy Gamelli, Breda Munoz, Janet S Hildebrand, Julie M Crawford, Lawrence F Eichenfield, on behalf of TARGET-DERM Investigators
634 - Lebrikizumab Directly Reverses IL-13 Driven Neuronal Gene Regulation and Neuronal Excitability
Yannick Miron, Paul E. Miller, Chloe Hughes, Ethan A. Lerner (Presenter), Ferda Cevikbas
638 - Improvement in Patient-Reported Symptoms and Quality of Life With Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Who Received Background Topical Therapy: Results of a 26-Week, Randomized, Head-to-Head Trial
Jacob P. Thyssen, H. Chih-ho Hong, Marjolein de Bruin-Weller, Roland Aschoff, April W. Armstrong, Raj Chovatiya, Christian Vestergaard, Ricardo Rojo, Hernan Valdez, Fan Zhang, Ankur Bhambri, Daniela E. Myers, Kimberly Watson, Erman Guler, Claire Clibborn, Marco DiBonaventura
639 - Rapid and Sustained Improvement in Skin Pain With Abrocitinib in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Jacob P. Thyssen, Anthony Bewley, Sonja Ständer, Brian Kim, Pinaki Biswas, Marco DiBonaventura, Melissa Watkins, Justine Alderfer, Erman Guler, Jonathan I. Silverberg
641 - The Use of Digital Health Technology to Measure Nocturnal Scratch and Sleep in Atopic Dermatitis: Response to Abrocitinib
Yao Zhang, Junrui Di, Yiorgos Christakis, Nikhil Mahadevan, Jonathan Bruno, and Carrie A. Northcott
642 - Long-Term Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Who Had Failed or Were Intolerant to Oral Non-Steroidal Immunosuppressants: Pooled Analysis of JADE Clinical Trials
Michael Ardern-Jones, Mahreen Ameen, Marjolein de Bruin-Weller, Eric Simpson, Wing Sin Chiu, Pinaki Biswas, Gary Chan, Christopher Koulias, Stephan Weidinger